ARTELO BIOSCIENCES, INC. Interest Expense
ARTELO BIOSCIENCES, INC. (ARTL) reported Interest Expense of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. interest expense for the quarter ending 2026-06-30 was $6.00K, a 91.67% decline year-over-year.
- ARTELO BIOSCIENCES, INC. interest expense for the quarter ending 2026-03-31 was $100.00K.
- ARTELO BIOSCIENCES, INC. interest expense for the quarter ending 2025-12-31 was $11.00K.
- ARTELO BIOSCIENCES, INC. interest expense for the quarter ending 2025-09-30 was $111.00K.
- ARTELO BIOSCIENCES, INC. interest expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ARTELO BIOSCIENCES, INC. interest expense for fiscal 2022 was $5.00K.
- ARTELO BIOSCIENCES, INC. interest expense for fiscal 2021 was $0.00.
- ARTELO BIOSCIENCES, INC. interest expense for fiscal 2017 was $2.10K.
| Period end | Interest Expense 3 month | Interest Expense 4 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-12 | $106.00K 10-Q · filed 2026-08-12 | $117.00K derived: sum of 3 quarters · filed 2026-08-12 | $228.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-14 | $111.00K derived: sum of 2 quarters · filed 2026-05-14 | $222.00K derived: sum of 3 quarters · filed 2026-05-14 | $294.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $11.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $122.00K derived: sum of 2 quarters · filed 2026-03-17 | $194.00K derived: sum of 3 quarters · filed 2026-08-12 | $194.00K 8-K · filed 2026-03-17 | |
| 2025-09-30 | $111.00K 10-Q · filed 2025-11-12 | $183.00K derived: sum of 2 quarters · filed 2026-08-12 | $183.00K 10-Q · filed 2025-11-12 | $183.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $72.00K 10-Q · filed 2026-08-12 | $72.00K 10-Q · filed 2026-08-12 | $72.00K derived: sum of 3 quarters · filed 2026-08-12 | $72.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 8-K · filed 2026-03-17 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $5.00K derived: sum of 2 quarters · filed 2024-03-25 | $5.00K 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $5.00K 10-Q · filed 2023-11-13 | $5.00K 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-08-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2017-08-31 | $177.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $1.08K derived: sum of 2 quarters · filed 2018-11-29 | $2.10K derived: sum of 3 quarters · filed 2018-11-29 | $2.10K 10-K · filed 2018-11-29 | |
| 2017-05-31 | $907.00 10-Q · filed 2018-07-13 | $1.92K derived: sum of 2 quarters · filed 2018-07-13 | $1.92K 10-Q · filed 2018-07-13 | ||
| 2017-02-28 | $1.02K 10-Q/A · filed 2018-05-14 | $1.02K 10-Q/A · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |